Krynica Vitamin (WAR:KVT) Cyclically Adjusted Revenue per Share: zł35.79 (As of Mar. 2026)


WAR:KVT Krynica Vitamin SA WAR:KVT
70 GF Score
Price zł12.80
GF Value zł10.40
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Krynica Vitamin Cyclically Adjusted Revenue per Share?

Krynica Vitamin WAR:KVT -2.66% 70 Cyclically Adjusted Revenue per Share is zł35.79 as of Mar. 2026. GuruFocus rates WAR:KVT with a GF Score™ of 70/100 and a GF Value™ of zł10.40 (Modestly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Krynica Vitamin's adjusted revenue per share for the three months ended in Mar. 2026 was zł6.962. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł35.79 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Krynica Vitamin's average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-12), Krynica Vitamin's current stock price is zł12.80. Krynica Vitamin's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł35.79. Krynica Vitamin's Cyclically Adjusted PS Ratio of today is 0.36.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Krynica Vitamin was 0.38. The lowest was 0.24. And the median was 0.30.


Krynica Vitamin  (WAR:KVT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Krynica Vitamin's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.80/35.79
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Krynica Vitamin was 0.38. The lowest was 0.24. And the median was 0.30.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Krynica Vitamin Cyclically Adjusted Revenue per Share Related Terms


Krynica Vitamin Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Krynica Vitamin's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krynica Vitamin Cyclically Adjusted Revenue per Share Chart

Krynica Vitamin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 33.13 34.54

Krynica Vitamin Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.84 34.04 34.23 34.54 35.79

WAR:KVT vs KO, PEP, MNST: Cyclically Adjusted Revenue per Share Comparison

For the Beverages - Non-Alcoholic subindustry, Krynica Vitamin's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krynica Vitamin Cyclically Adjusted PS Ratio vs Beverages - Non-Alcoholic Industry

For the Beverages - Non-Alcoholic industry and Consumer Defensive sector, Krynica Vitamin's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Krynica Vitamin's Cyclically Adjusted PS Ratio falls into.


WAR:KVT
70GF Score
Krynica Vitamin SA WAR:KVT
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krynica Vitamin Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Krynica Vitamin's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.962/163.0700*163.0700
=6.962

Current CPI (Mar. 2026) = 163.0700.

Krynica Vitamin Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.605 99.552 7.543
201609 3.605 99.064 5.934
201612 2.556 100.366 4.153
201703 3.254 101.018 5.253
201706 4.744 101.180 7.646
201709 4.663 101.343 7.503
201712 4.132 102.564 6.570
201803 4.484 102.564 7.129
201806 5.868 103.378 9.256
201809 6.468 103.378 10.203
201812 5.158 103.785 8.104
201903 4.260 104.274 6.662
201906 6.981 105.983 10.741
201909 7.806 105.983 12.011
201912 5.176 107.123 7.879
202003 5.623 109.076 8.406
202006 15.899 109.402 23.698
202009 7.841 109.320 11.696
202012 7.051 109.565 10.494
202103 6.837 112.658 9.896
202106 9.726 113.960 13.917
202109 8.397 115.588 11.846
202112 7.339 119.088 10.049
202203 6.388 125.031 8.331
202206 8.243 131.705 10.206
202209 8.628 135.531 10.381
202212 7.524 139.113 8.820
202303 5.309 145.950 5.932
202306 7.788 147.009 8.639
202309 9.586 146.113 10.698
202312 6.630 147.741 7.318
202403 6.693 149.044 7.323
202406 8.679 150.997 9.373
202409 9.211 153.439 9.789
202412 7.049 154.660 7.432
202503 6.495 157.021 6.745
202506 8.769 157.509 9.079
202509 8.229 158.000 8.493
202512 5.592 158.320 5.760
202603 6.962 163.070 6.962

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł35.79 mean?
Krynica Vitamin (WAR:KVT) has a Cyclically Adjusted Revenue per Share of zł35.79 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krynica Vitamin and its competitors.
Is Krynica Vitamin's Cyclically Adjusted Revenue per Share too high?
Krynica Vitamin's current Cyclically Adjusted Revenue per Share is zł35.79. Overall, Krynica Vitamin has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krynica Vitamin's Cyclically Adjusted Revenue per Share compare to KO and PEP?
Krynica Vitamin's Cyclically Adjusted Revenue per Share of zł35.79 can be compared against companies in the Beverages - Non-Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Beverages - Non-Alcoholic company?
A good Cyclically Adjusted Revenue per Share depends on the Beverages - Non-Alcoholic industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krynica Vitamin and its competitors. Krynica Vitamin's current Cyclically Adjusted Revenue per Share is zł35.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krynica Vitamin stock overvalued right now?
Based on GuruFocus' analysis, Krynica Vitamin (WAR:KVT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł10.40, compared to a current price of zł12.80 — trading 23.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł35.79. Krynica Vitamin's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Krynica Vitamin (WAR:KVT), the current Cyclically Adjusted Revenue per Share is zł35.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krynica Vitamin (WAR:KVT) Overvalued in 2026?

Based on GuruFocus' analysis, Krynica Vitamin stock appears to be overvalued. The current stock price of zł12.80 is trading 23.1% above its estimated GF Value™ of zł10.40. GuruFocus considers Krynica Vitamin to be Modestly Overvalued.

Key valuation signals for WAR:KVT:

  • Cyclically Adjusted Revenue per Share: zł35.79
  • GF Value™: zł10.40 vs. price of zł12.80 (23.1% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the WAR:KVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krynica Vitamin Business Description

Address Ulica Matyldy 35, Warsaw, POL, 03-606
Krynica Vitamin SA is a Polish producer of non-alcoholic and low-alcoholic beverages. The company is engaged in producing beverages for own brands and providing bottling services for brand-name products. It offer includes functional and energy drinks such as isotonic and hypotonic drinks, beverages that support metabolism, and diet supplementary vitamin drinks. It also offers functional waters, modern mixed-fruit drinks, drinks with fruit pulp, alcopops, ciders, malt beverages and a wide selection of carbonated beverages.
70GF Score

Get the complete analysis for WAR:KVT

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł12.80
Price
zł10.40
GF Value